# SCRIMED Global Partner And Buyer Localization Brief

Status: global-partner-localization-layer-ready
Boundary: SCRIMED Global Reach organizes region, buyer, partner, procurement, deployment, and localization readiness for governed synthetic pilots and enterprise evaluations. It is not legal advice, privacy advice, tax advice, regional regulatory approval, public-sector procurement approval, reimbursement assurance, compliance certification, clinical validation, production authorization, or live clinical execution authority.

## Region Focus
- United States (launch): Start with synthetic workflow intelligence assessments and protected enterprise pilots before PHI, payer, or EHR integration. Retained gates: signed enterprise scope, BAA/DPA where applicable, security review, clinical governance review, production connector approval.
- UAE (strategic): Position SCRIMED Atlas as a sovereign-ready healthcare intelligence operating layer evaluated through synthetic evidence. Retained gates: regional counsel review, hosting and residency approval, public-sector procurement process, qualified local implementation partner, translation and claims review.
- Saudi Arabia (strategic): Lead with strategic platform partnership, workforce efficiency, governance, and sovereign deployment readiness. Retained gates: regional counsel review, government procurement authority, data-residency approval, cybersecurity review, partner authority validation.
- Kuwait (strategic): Use a controlled synthetic evaluation to prove workflow intelligence before local hosting or production integration decisions. Retained gates: qualified local partner, regional counsel review, buyer procurement process, data residency decision, customer go-live approval.
- Nigeria (launch): Lead with access, workflow efficiency, education, FaithCore optionality, and lightweight synthetic pilots before production data integrations. Retained gates: local privacy review, public-sector authority where applicable, customer data-processing agreement, clinical governance reviewer, production support model.
- Kenya (strategic): Use interoperability, workflow intelligence, population-health readiness, and education partnerships as the entry wedge. Retained gates: local counsel review, partner authority validation, data-sharing approval, clinical governance review, production incident-response plan.
- Rwanda (strategic): Position as healthcare intelligence infrastructure for public-sector innovation, synthetic pilots, and carefully governed deployment planning. Retained gates: public-sector procurement review, local counsel review, implementation partner qualification, data-residency decision, official approval before public naming.
- Ghana (strategic): Lead with access, administrative workflow intelligence, training, and protected synthetic pilots before live healthcare data. Retained gates: local privacy review, clinical governance reviewer, production support owner, customer approval, partner authority validation.
- European Union and United Kingdom (watch): Use compliance-forward synthetic evaluations and private/sovereign deployment planning before any production data handling. Retained gates: regional counsel review, DPA and transfer assessment, clinical safety classification, AI governance review, country-level localization approval.

## Buyer Packs
- Provider and health-system executives: Workflow Intelligence Assessment -> Synthetic Pilot Evaluation -> Protected Enterprise Pilot. Entry: /product. Boundary disqualifiers: Requests autonomous diagnosis, Requires live PHI in public intake, Wants immediate EHR writeback without governance.
- Payers, plans, and revenue-cycle leaders: Synthetic Pilot Evaluation -> RCM and Prior Authorization Blueprint -> Protected Enterprise Pilot. Entry: /pricing. Boundary disqualifiers: Requests reimbursement guarantee, Requires payer submission automation before approval, Asks SCRIMED to make coverage determinations.
- Government and public-sector healthcare leaders: Strategic Platform Partnership. Entry: /deployment-profiles. Boundary disqualifiers: Requests government approval claim before authorization, Requires public health reporting before implementation review, Needs live citizen data in evaluation.
- Life sciences, research networks, oncology programs, and trial operations: TrialCore Research Operations Synthetic Pilot. Entry: /modules/trialcore. Boundary disqualifiers: Requests patient enrollment action, Requires treatment recommendation, Bypasses research governance or ethics review.
- Employers and benefits leaders: Workflow Intelligence Assessment. Entry: /pilot. Boundary disqualifiers: Requests employee diagnosis, Requires member data before agreements, Wants patient outreach without consent.
- Global channel partners and healthcare implementers: Strategic Platform Partnership. Entry: /global-reach. Boundary disqualifiers: Claims unauthorized SCRIMED partnership, Requests resale before legal review, Cannot support healthcare-grade security and governance.
- Investors, advisors, and board reviewers: Investor and Board Readiness Review. Entry: /public-market-readiness. Boundary disqualifiers: Requests valuation guarantee, Treats operating metrics as audited financials, Uses materials as securities offering content.

## Partner Channels
- Healthcare systems integrator channel (qualification-required): Partner qualification -> legal and claims review -> synthetic demo enablement -> co-sell pilot -> protected implementation plan.. Blocked claims: official SCRIMED partner without signed agreement, certified implementation partner, authorized production deployment partner.
- Public-sector and sovereign health channel (qualification-required): Authority mapping -> regional counsel review -> public-sector proof pack -> procurement pathway -> synthetic evaluation.. Blocked claims: government approved, national platform selected, public-sector authorization granted.
- Faith-aligned community and care channel (ready-for-controlled-outreach): FaithCore briefing -> consent and boundary review -> community education pilot -> clinical-governance review for any care-adjacent workflows.. Blocked claims: spiritual guidance replaces care, emergency support, clinical advice through FaithCore.
- Research and life-sciences channel (qualification-required): Synthetic protocol pack -> research governance review -> evidence-gap demo -> protected pilot design.. Blocked claims: patient enrollment guarantee, treatment recommendation, IRB approval.

## Boundary Resolutions
- Regional legal and privacy approval: Use region packs as intake and diligence routing only; require qualified regional counsel, customer legal review, and externally retained approval artifacts before production. Retained gate: Regional counsel and customer legal approval.
- PHI, patient identifiers, payer member data, and production records: Keep all public and global intake synthetic-only; route any protected data request to gated enterprise scope, BAA/DPA path, security review, and production data architecture. Retained gate: Signed customer scope, data-processing agreement, and PHI architecture approval.
- Clinical execution authority: Keep all region and audience packs review-only, non-diagnostic, and human-supervised; route care-adjacent requests to Clinical Care Activation gates. Retained gate: Licensed clinical governance, regulatory classification, validated workflow, and customer go-live approval.
- Security certification and procurement approval: Use Protected Procurement Evidence Registry and Provider Security Reviews to store metadata-only routing while sensitive artifacts remain externally retained. Retained gate: Qualified security review, approved artifact storage, and buyer procurement decision.
- Reimbursement, ROI, and audited financial claims: Route financial claims through Public Market Readiness, finance methodology gates, external approval evidence, and release decision workflow. Retained gate: Finance review, buyer-approved methodology, counsel review, and external-use approval.
- Localization, language, and cultural review: Treat localized copy as draft until region-specific review covers language, claims, clinical boundaries, faith posture, and public-sector sensitivities. Retained gate: Qualified translation, regional reviewer, claims register update, and release decision.
- Partner authority and channel claims: Require partner qualification, legal agreement, claims permissions, support ownership, and evidence-room controls before co-selling or public announcement. Retained gate: Signed partner agreement and approved partner claims pack.
- Public relations, advertising, and case-study release: Route all external-use claims through release decisions, named reviewer sign-offs, distribution lockbox, and release authority attestations. Retained gate: Customer permission, counsel review, marketing-claims approval, and distribution release.

## Competitive Edge
- Global buyer packs: SCRIMED maps each buyer segment to offer, proof routes, procurement questions, disqualifiers, and safe conversion path. Proof: /global-reach. Blocked claim: Does not mean local legal, privacy, procurement, or clinical approval is complete.
- Sovereign-ready architecture story: Deployment profiles and region packs let SCRIMED sell cloud, private, hospital-controlled, sovereign, and edge/on-prem planning without moving live data. Proof: /deployment-profiles. Blocked claim: Does not mean any sovereign deployment has been approved or implemented.
- Procurement-safe expansion: Protected procurement and provider-security routes capture metadata-only readiness while sensitive artifacts stay externally retained. Proof: /pilot-workspace/access. Blocked claim: Does not store SOC reports, pentest findings, signed contracts, credentials, or questionnaire answers.
- FaithCore optionality: FaithCore is positioned as opt-in trust and encouragement support while clinical judgment remains with qualified professionals. Proof: /faithcore. Blocked claim: Does not replace clinical care, emergency support, counseling, or medical advice.
- Capital-efficient global motion: SCRIMED prioritizes region packs, partner channels, premium pilots, and proof-to-revenue metrics before scaling spend. Proof: /public-market-readiness. Blocked claim: Does not guarantee valuation, fundraising, revenue, reimbursement, or audited financial outcomes.

## Activation Sequence
- 1. Segment and region fit: Classify the buyer by audience, region, deployment constraint, proof need, and commercial path. Exit: Buyer has a selected localization pack, region focus, and safe first offer without PHI or live clinical scope.
- 2. Claims and procurement preflight: Check whether the buyer needs legal, privacy, security, procurement, public-sector, or partner evidence before deeper sales motion. Exit: Required proof routes and retained approval gates are identified before external promises.
- 3. Synthetic pilot or assessment: Run a no-PHI evaluation that proves workflow value, buyer fit, deployment path, and evidence quality. Exit: Buyer receives controlled pilot evidence, measurable operational signals, and next-step governance requirements.
- 4. Protected enterprise planning: Move only qualified buyers into protected workspaces, procurement routing, partner planning, and production-readiness gates. Exit: AAL2 workspace evidence, roles, audit trail, procurement metadata, and retained hard gates are explicit.

Next build step: Add protected partner qualification records and localized buyer-pack packet exports after legal review approves the partner claims workflow.